Clinical Laserthermia Systems AB (publ)
Super Stock+54.3%In short
- Clinical Laserthermia Systems has fallen 80.2% over the past year, including dividends.
- Overall, Clinical Laserthermia Systems ranks better than 12% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 98.7%. The price is 99.9% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 12% of Nordic stocks.
- Equity ratioThe share of assets that is owned, not borrowed71.9%
- Return on assetsProfit divided by everything the company owns−59.3%
- Return on equityProfit divided by equity−82.6%
- Debt to equityBorrowings divided by equity0.01
The ranking is built on equity ratio, ROA and how steadily profit grows.
- P/EPrice divided by earningsnegative earnings
- P/BPrice divided by equity1.1
- P/SPrice divided by sales4.2
- DividendPast year's dividend divided by the price0.0%
The ranking is built on P/E, P/B and P/S.
- 3 months−48.8%
- 6 months−59.9%
- 12–1 monthsThe past year without the last month, as in the research−78.8%
- 1 year−80.2%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Clinical Laserthermia Systems
Clinical Laserthermia Systems AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 13 employees.
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. The company has a strategic partnership with ClearPoint Neuro Inc. for the development of ClearPoint Prism, a Neuro Laser Therapy System.
See the full analysis of Clinical Laserthermia Systems.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card
